Migraine in Children: How It Looks Different

Written and medically reviewed by Tae Ho Guak, MD, board-certified neurologist · Reviewed July 2026 · Editorial policy

Summary: Migraine in children and adolescents is the same “migraine” as in adults, but with shorter attack duration (recognized from 2 hours), bilateral presentation (particularly fronto-temporal), and more prominent nausea, vomiting, and abdominal pain relative to headache itself. This article reviews ICHD-3 diagnostic criteria for pediatric and adolescent migraine, differences from adults, safe acute and preventive treatment strategies, and home-based lifestyle management principles.

Medical Background — Why Should Pediatric Migraine Be Addressed Separately?

Migraine is a common neurological disorder affecting approximately 7–10% of school-age children and 15–20% of adolescents. Before puberty, boys are equally or more affected than girls; however, after puberty, girls account for approximately 2–3 times more cases (Abu-Arafeh 2010, Dev Med Child Neurol). It is a major cause of school absences and academic decline and is recognized as a risk factor for chronic migraine in adulthood, making early diagnosis and treatment important.

The pathophysiology is explained by the same trigeminovascular activation and CGRP-mediated neuroinflammation model as in adults; however, the clinical phenotype differs as follows:

• Shorter duration: While adults require 4–72 hours, children under 18 years may have attacks lasting 2–72 hours (ICHD-3, 1.1 Note).
• Bilateral and fronto-temporal distribution is common: Rather than the unilateral throbbing typical in adults, children often present with bilateral frontal and temporal pressure sensations, which can be confused with tension-type headache.
• Gastrointestinal symptoms are prominent: Nausea, vomiting, and abdominal pain may be more bothersome than the headache itself. Associated “childhood periodic syndromes” (ICHD-3 1.6) such as abdominal migraine, cyclic vomiting syndrome (CVS), and benign paroxysmal vertigo (BPV) may occur.
• Autonomic symptoms: Pallor, lethargy, and drowsiness (“symptom relief with sleep”) are more common than in adults.

Diagnosis and Differentiation — Applying ICHD-3 Pediatric Criteria

ICHD-3 does not establish a separate “pediatric migraine” classification but applies the following footnotes to the adult diagnostic criteria (1.1 migraine without aura):

• Duration: 2–72 hours (untreated).
• Location: Bilateral presentation is acceptable (especially fronto-temporal).
• Minimum 5 attacks plus ≥2 of the following: pulsating quality, moderate to severe intensity, worsening with physical activity, aggravation by daily activities.
• During the attack, ≥1 of the following: nausea/vomiting or photophobia/phonophobia (in younger children, behavioral signs are considered).
• Not better explained by another disorder.

Differential diagnosis should be approached as follows:

• Tension-type headache: Bilateral pressing quality, not worsened by physical activity, nausea/vomiting rare.
• Abdominal migraine (ICHD-3 1.6.1.2): ≥5 episodes of moderate to severe abdominal pain lasting 1–72 hours, with dull, periumbilical character and accompanying nausea, appetite loss, or pallor; normal between attacks.
• Secondary headache red flags (see “Red Flags” section below).
• Medication overuse headache (MOH): Can occur in adolescents; suspect if simple analgesics are used ≥15 days/month or triptans/combination analgesics ≥10 days/month.
• Refractive error, temporomandibular joint disorder, sinusitis: Common non-neurological causes.

A headache diary (2–4 weeks) documenting frequency, duration, medication use, and triggers (sleep deprivation, skipped meals, academic stress, screen exposure, menses) significantly improves diagnostic accuracy and treatment response evaluation.

Treatment — Acute Phase and Prevention: What Are the Differences?

Acute Phase Treatment (2018 AAN/AHS Practice Guideline, Oskoui et al.)

• Ibuprofen 7.5–10 mg/kg (maximum 400–600 mg): First-line choice. Gastrointestinal burden can be reduced by taking with food.
• Acetaminophen 15 mg/kg: Second-line option. Efficacy may be somewhat lower than ibuprofen.
• Triptans: FDA-approved agents in adolescents (≥12 years) include rizatriptan (approved for ages 6–17), almotriptan, and nasal zolmitriptan (for ages ≥12). Off-label use in children ≥6 years should be considered with pediatric neurology consultation.
• Combination therapy: Ibuprofen + triptan is superior to either agent alone (extrapolated from adult data).
• For severe nausea/vomiting: Consider nasal zolmitriptan, oral dissolving tablets, or ondansetron.
• Medications to avoid: Aspirin (risk of Reye syndrome in children <16 years), opioid analgesics (addiction and MOH risk), caffeine-containing combination products.

Preventive therapy should be considered for headaches occurring ≥4 times per month, moderate severity causing school absences or functional impairment, poor response to acute treatment, or presence of prolonged aura or motor deficits.

The CHAMP trial (Powers 2017, NEJM) showed that amitriptyline and topiramate did not demonstrate superiority over placebo. This has shifted the approach toward using cognitive-behavioral therapy (CBT) + lifestyle modifications as the core strategy rather than starting prophylactic medication unconditionally.

• Medication options: Topiramate (2–4 mg/kg), amitriptyline (0.25–1 mg/kg at bedtime), propranolol, riboflavin B2 (200–400 mg), coenzyme Q10 (1–3 mg/kg), magnesium (9 mg/kg), etc. Individualize based on adverse effect profiles (weight, cognition, mood).
• CGRP monoclonal antibodies and gepants: Pediatric indications are currently limited, with clinical trials ongoing. Consider expert consultation for refractory adolescent cases.
• Non-pharmacological interventions: CBT, biofeedback, and relaxation training have accumulated strong evidence (level B or higher).

Self-Management and Prevention — Five Most Important Things at Home

If a child complains of headaches weekly, there are lifestyle factors to check before relying on medication. The following five are the “fundamentals” most frequently emphasized by physicians in outpatient settings:

1. Sleep — consistent daily timing: School-age children need 9–11 hours; adolescents need 8–10 hours. “Binge sleeping” on weekends is often a major trigger for Monday migraines.
2. Never skip breakfast: Fasting and hypoglycemia are powerful triggers. A breakfast including protein is beneficial.
3. Fluid intake: Target 30–40 mL per kilogram of body weight daily. Increase during exercise, heat exposure, and around menses.
4. Screen time and posture: Take a 10-minute break after 60 minutes of screen use (20-20-20 rule); position monitors at eye level. “Time control” is more important than blue light filters.
5. Headache diary: Briefly record frequency, duration, medications, and triggers (review weekly). Co-authoring with parents facilitates communication at both school and medical visits.

To prevent medication overuse headache (MOH), establish a household rule: simple analgesics ≤14 days/month, triptans/combination analgesics ≤9 days/month.

Red Flags — Headaches Requiring Immediate Medical Evaluation

If any of the following apply, do not dismiss as “simple migraine” and seek neurological evaluation (with imaging if indicated). Secondary headache frequency is higher in children than in adults.

• Sudden-onset thunderclap headache of maximal intensity.
• Head pain awakening the child in the morning or accompanied by vomiting (especially worsening with positional changes).
• Associated fever, neck stiffness, or rash.
• Newly developed neurological deficits (vision, strength, speech, balance).
• Seizures, altered consciousness, or sudden behavioral/cognitive changes.
• Rapidly changing headache pattern or progressive severity over weeks to months.
• Age <6 years, or comorbid conditions (cancer, ventriculoperitoneal shunt, immunodeficiency).
• Headache following head trauma.

Closing Remarks — One Point Physicians Emphasize to Parents

Pediatric and adolescent migraine is not “malingering” but a diagnosable neurological disorder. Rather than fixating on a single medication, a four-step approach—accurate diagnosis → safe acute-phase pharmacotherapy → lifestyle modification and cognitive-behavioral therapy → preventive therapy when indicated—enables most children to maintain school attendance and extracurricular activities throughout their development. If attack frequency increases or medication dependence develops, consultation with pediatric neurology or pediatric specialists is recommended at that point.

This article is provided for medical information purposes and does not replace individual diagnosis and treatment. Medication selection and dosage determination must always be discussed with your healthcare provider.